Leiah J Brigitha

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Oxide Nanoparticles

Cerebrospinal Fluid

Allogeneic Hematopoietic Stem Cell Transplantation

Palliative Care

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Pharmaceutical research

Therapeutic drug monitoring

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Leiah J Brigitha, Veerle Mondelaers, Yiwei Liu, Birgitte K Albertsen, Beata Zalewska-Szewczyk, Carmelo Rizzari, Rishi S Kotecha, Rob Pieters, Alwin D R Huitema, Inge M van der Sluis
Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia. Pharmaceutical research 41 (4) (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Leiah J Brigitha, Karen Zaky, Rob Pieters, Inge M van der Sluis
A Refined Population Pharmacokinetic Model-Based Guideline for Individualized PEGasparaginase Dosing in Pediatric Acute Lymphoblastic Leukemia. Therapeutic drug monitoring (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Leiah J Brigitha, Veerle Mondelaers, Yiwei Liu, Birgitte K Albertsen, Beata Zalewska-Szewczyk, Carmelo Rizzari, Rishi S Kotecha, Rob Pieters, Alwin D R Huitema, Inge M van der Sluis
Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia. Pharmaceutical research (2024)
Leiah J Brigitha, Veerle Mondelaers, Yiwei Liu, Birgitte K Albertsen, Beata Zalewska-Szewczyk, Carmelo Rizzari, Rishi S Kotecha, Rob Pieters, Alwin D R Huitema, Inge M van der Sluis
Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia. Pharmaceutical research 41 (4) (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Inge M Van der Sluis, Leiah J Brigitha, Marta Fiocco, Hester A de Groot-Kruseman, Marc Bierings, Cor van den Bos, Valerie de Haas, Peter M Hoogerbrugge, Wim J E Tissing, Margreet A Veening, Rob Pieters
Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Leiah J Brigitha, Rob Pieters, Eduard A Struys, Abdellatif Bakkali, Inge M Van der Sluis
Depletion of d- and l-asparagine in cerebrospinal fluid in acute lymphoblastic leukemia during PEGasparaginase therapy. Pediatric blood & cancer 69 (11) (2022)